Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Postmenopausal Hormone Therapy Reduces Risk for Some Cancers

Use of hormone therapy for menopause is associated with reduced risks for esophageal, gastric, and colorectal cancers, according to results of a prospective study that were then combined with published studies in a meta-analysis. In this British study of women aged 50 to 64 years, researchers found no significant differences in risk by type of hormone therapy, duration of use, or between past and current users. The reduction in risk, however, was small in comparison to the increased risk of breast cancer that has been attributed to hormone therapy in this population.

 

Complete study results are available as an accepted manuscript on the website of the International Journal of Cancer (http://onlinelibrary.wiley.com.proxy.libraries.rutgers.edu/doi/10.1002/ijc.26236/abstract).

Related Items
Oral Toxicities Associated with Cancer Therapies: What's Old Is New Again
Meg Barbor, MPH
Web Exclusives published on November 26, 2018 in Drug Therapies
Current Treatment Options for the Management of Glioblastoma Multiforme
Larry W. Buie, PharmD, BCPS, BCOP, John M. Valgus, PharmD, BCOP, CPP
JHOP - June 2012, Vol 2, No 2 published on July 6, 2012 in Drug Therapies
The Evolution of Tyrosine Kinase Inhibitor Therapy: Improving Outcomes in Patients with Newly Diagnosed Chronic Myelogenous Leukemia
Natalie J. Greisl, PharmD, Christopher A. Fausel, PharmD, BCPS, BCOP
JHOP - December 2011 VOL 1, NO 4 published on January 6, 2012 in Drug Therapies
Current Practice in the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Adults
Lisa K. Lohr, PharmD, BCOP, BCPS
JHOP - December 2011 VOL 1, NO 4 published on January 5, 2012 in Drug Therapies
A New Drug Therapy for HER2+ Breast Cancer May Be on the Horizon
TON - Daily published on July 27, 2011 in Drug Therapies
Hsp90 Inhibition Counters JAK/STAT-Signaling Diseases
TOP - Daily published on June 1, 2011 in Drug Therapies
Noninvasive Imaging Predicts Trastuzumab-Mediated Cardiomyopathy
TON - Daily published on May 31, 2011 in Drug Therapies
Preoperative Anti-HER2 Agents Yield Benefits
Caroline Helwick
Web Exclusives published on December 23, 2010 in Drug Therapies, In the News
Last modified: September 8, 2015